Literature DB >> 31069901

Homozygous variants in the gene SCAPER cause syndromic intellectual disability.

Kimia Kahrizi1, Mareike Huber2, Danuta Galetzka2, Sri Dewi2, Julia Schröder2, Eva Weis2, Ariana Kariminejad1, Zoherh Fattahi1, Hans-Hilger Ropers2,3, Susann Schweiger2,4, Hossein Najmabadi1, Jennifer Winter2,4.   

Abstract

The S-Phase Cyclin A Associated Protein In The ER (SCAPER) gene is a ubiquitously expressed gene with unknown function in the brain. Recently, biallelic SCAPER variants were described in four patients from three families with retinitis pigmentosa (RP) and intellectual disability (ID). Here, we expand the spectrum of pathogenic variants in SCAPER and report on 10 further patients from four families with ID, RP, and additional dysmorphic features carrying homozygous variants in SCAPER. The variants found comprise frameshift, nonsense, and missense variants as well as an intragenic homozygous deletion, which spans SCAPER exons 15 and 16 and introduces a frameshift and a premature stop codon. Analyses of SCAPER expression in human and mouse brain revealed an upregulation of SCAPER expression during cortical development and a higher expression of SCAPER in neurons compared to neural progenitors. In the adult brain SCAPER is expressed in several regions including the cerebral cortex where it shows a layer-specific expression with an expression peak in lower layer glutamatergic neurons. Our study supports the role of SCAPER variants in the pathogenesis of ID and RP, expands the variant spectrum and highlights the need for functional studies concerning the role of SCAPER during brain development and function.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  RP; SCAPER; intellectual disability

Mesh:

Substances:

Year:  2019        PMID: 31069901     DOI: 10.1002/ajmg.a.61172

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  1 in total

Review 1.  First observation of secondary childhood glaucoma in Coffin-Siris syndrome: a case report and literature review.

Authors:  Oliver Bartsch; Esther M Hoffmann; Heidi Diel; Can Ding; Franz Grehn; Panagiotis Chronopoulos
Journal:  BMC Ophthalmol       Date:  2021-01-11       Impact factor: 2.209

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.